MedTrace Logo

Transcranial Direct Current Stimulation (tDCS) Improves Functional Outcomes in Acute Stroke Patients

NCT03888209 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-04-03

No results posted yet for this study

Summary

Acute stroke patient will undergo one month (20 sessions) of physical therapy and anodal tDCS.

Patients will undergo functional outcomes measured at 48h post onset, 7,14,21,28 days, 3 and 6 months and one year post onset.

Conditions

  • Stroke, Acute

Interventions

DEVICE

tDCS

20 minutes of anodal tDCS (C3/FP2 or C4/FP1 depending on side of lesion) 2mA or sham

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Stephen Bornheim, Msc · Liege Univeristy Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-31
Primary Completion
2020-06-30
Completion
2020-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03888209 on ClinicalTrials.gov